Vivela Skin Booster – Italian Hybrid HA
New Italian skin booster

Deep hydration and dynamic lift
with Italian hybrid hyaluronic acid.

Vivela Skin Booster 64 mg combines high and low molecular weight hyaluronic acid in a single, elegant injection protocol designed to re-energize lax, dehydrated skin without overfilling or heaviness.

64 mg HA (3.2%) 0% BDDE – biofermented Up to ~6 months longevity Face, neck, hands & body

For intradermal administration by licensed healthcare professionals only. Medical device – not for retail sale.

Vivela 64 mg / 2 ml
High & low molecular weight HA H-HA 32 mg + L-HA 32 mg
Vivela Skin Booster product packaging – Italian mesogel
Made in Italy · Sterile pre-filled syringe · 2 needles included
About Vivela

High-performance anti-aging that feels weightless on the skin.

Vivela Skin Booster is a next-generation injectable designed in Italy to target hydration, elasticity and tissue quality through a balanced combination of high and low molecular weight hyaluronic acid in a single non-crosslinked formula.

Biorevitalization

Deep, dynamic hydration

Low molecular weight HA infuses the dermis with water, restoring glow to dull, fatigued skin and creating the ideal environment for keratinocyte and fibroblast activity.

Tissue remodeling

Lift without over-volumizing

High molecular weight HA delivers a subtle lifting and tightening effect, improving laxity and contour while preserving the natural anatomy and expression of the face.

Comfort & control

Silky rheology for smooth injections

Patented hybrid technology allows high HA concentration with reduced viscosity, enabling precise, homogeneous spread and improved control for the injector.

Hybrid Technology

Italian formulation, biofermented hyaluronic acid.

Vivela Skin Booster contains hyaluronic acid sodium salt obtained by biofermentation, without chemical modification or crosslinking agents such as BDDE. High and low molecular weight chains interact through a dedicated hybrid process, generating a unique rheological profile.

  • 3.2% HA concentration – 64 mg in a 2 ml pre-filled syringe.
  • High molecular weight H-HA (32 mg) for mechanical lift and structure.
  • Low molecular weight L-HA (32 mg) for deep, long-lasting hydration.
  • Buffered physiological solution with sodium chloride and sodium phosphate.
  • Sterilized by moist heat; needles sterilized with ethylene oxide.

0% BDDE · Excellent biocompatibility · Integrates with endogenous HA in the dermis.

Key technical advantages

  • Reduced viscosity for effortless injections and gentle extrusion force.
  • Even gel distribution under the skin for smooth, natural contours.
  • Minimal risk of post-treatment inflammation or nodularity.
  • Compatible with platelet-rich plasma (PRP) without altering viscosity.
  • Impressive effects longevity – typically around six months.
Indications

Designed for laxity, dehydration and scarred skin.

Vivela acts via corrective filling and regenerative support of natural or induced cutaneous depressions. It is indicated wherever tissue quality and hydration are compromised by aging, environmental stress or superficial trauma.

  • Physiological skin aging with loss of turgor, tone and elasticity.
  • Fine lines, crepiness and diffuse photoaging.
  • Superficial atrophic scars, including acne and post-varicella.
  • Global texture improvement and dermal remodeling.
Chronological aging Photoaging Post-acne scars Post-trauma skin Preventive protocols

Target treatment areas

Vivela Skin Booster is suitable for both face and body, particularly where the skin appears loose, thin or dehydrated.

  • Malar–zygomatic and sub-malar regions.
  • Mandibular contour and chin redefining.
  • Neck and décolleté.
  • Dorsum of the hands.
  • Inner arms and brachial region.
  • Abdomen and localized areas of laxity.
Protocol

Simple, efficient treatment plan for long-lasting results.

Vivela is injected intradermally or at the dermal–subcutaneous interface using bolus injections at anatomically defined Bio Aesthetic Points (BAP). The protocol is easy to integrate into existing anti-aging and skin quality programs.

Recommended treatment schedule

1
Session 1

Initial intradermal treatment with 2 ml Vivela, distributed in boluses over key points.

2
Session 2 – after 30 days

Second full session reinforces hydration, mechanical lift and collagen stimulation.

3
Maintenance

Optional maintenance session every 2 months, tailored to the patient’s degree of aging, lifestyle and expectations.

Injection technique highlights

  • Inject at room temperature under strict aseptic conditions.
  • 0.2 ml bolus per point in dermal or sub-dermal planes.
  • Gentle massage at each point to support homogeneous spread.
  • Do not mix with other products in the same syringe.
  • Do not inject intravenously, intramuscularly, into tendons or for breast augmentation.
Science & Safety

Biocompatible by design, tested for everyday practice.

The hyaluronic acid in Vivela is produced via biosynthesis from a natural substrate, with no further chemical modification. When injected into the dermis it integrates smoothly with endogenous HA that has been depleted or structurally altered by aging or trauma.

In vitro tests have confirmed compatibility with platelet rich plasma (PRP), with no adverse impact on the rheological behavior of the gel. Clinical feedback reports excellent tolerability and absence of serious adverse events.

Bio-fermented Non-animal origin, designed for optimal biocompatibility.
0% BDDE No chemical crosslinker, preserving tissue friendliness.
~6 months Typical duration of visible effects in standard protocols.

Expected post-treatment reactions

Transient, mild adverse events may occur around injection sites and generally resolve spontaneously within a short time.

  • Localized pain or tenderness.
  • Redness, warmth or slight swelling.
  • Occasional small bruises at needle entry points.

Cooling the treated area with ice packs can help alleviate discomfort. Physicians should instruct patients to report any unexpected or persistent effects.

Contraindications & precautions

  • Do not use concurrently with laser resurfacing or medium/deep chemical peels.
  • Do not inject into infected, inflamed or compromised skin.
  • Single-use sterile device – do not resterilize or reuse.
  • Store between 0°C and 25°C. Do not freeze. Keep out of reach of children.

For professional use only. Intradermal injections must be performed by a qualified medical practitioner in accordance with local regulations.

FAQ

Frequently asked questions from medical professionals.

How is Vivela different from a traditional dermal filler?

Vivela is a skin booster focused on hydration, elasticity and tissue quality rather than volumetric augmentation. Its non-crosslinked hybrid HA formulation spreads evenly through the dermis, improving texture and turgor with minimal impact on facial volume.

How long do results typically last?

Most patients experience visible improvements for around six months after a complete treatment cycle, although longevity depends on age, skin condition and lifestyle factors.

Can Vivela be combined with other procedures?

Vivela can be integrated into comprehensive anti-aging plans alongside neuromodulators, energy-based devices and other injectables, provided appropriate spacing and safety considerations are respected. It must not be used in the same session as medium or deep peels or ablative laser resurfacing in the treated area.

Contact

Italian origin, global ambition. Let’s connect.

For medical information, training opportunities or distribution inquiries, reach out to our team. Vivela Skin Booster is manufactured in Italy in a dedicated pharmaceutical industrial park.

Corporate & manufacturing address

  • Vivela Biorejuvenation Labs
  • Via Farmaceutica 12, Pharma Industrial Park
    40064 Ozzano dell’Emilia (BO), Italy

Emails

Replace the email domain with your official website domain when deploying this page.

Fluent Forms